NCT05831111 2025-09-30A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1195, in 18- to 55-Year-Old Healthy ParticipantsModernaTX, Inc.Phase 1 Active not recruiting482 enrolled
NCT04645147 2025-07-17Safety and Immunogenicity of an Epstein-Barr Virus (EBV) gp350-Ferritin Nanoparticle Vaccine in Healthy Adults With or Without EBV InfectionNational Institutes of Health Clinical Center (CC)Phase 1 Active not recruiting83 enrolled